After cutting 60% of its staff last December, Instil Bio is back with another round of layoffs. In this latest round, 15 employees in the cell therapy biotech’s U.S. manufacturing operations in California will be heading out the door. Manufacturing and clinical trial operations for the company’s CoStAR-TIL platform will shift to Manchester, U.K., where the team has been working on developing tumor-infiltrating lymphocyte. Source: Fierce Biotech 1/2/2023